Chugai Pharmaceutical Co Stock Investor Sentiment

CHGCF Stock  USD 42.25  2.55  5.69%   
Roughly 61% of Chugai Pharmaceutical's investor base is looking to short. The analysis of overall sentiment of trading Chugai Pharmaceutical Co pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with Chugai Pharmaceutical's historical and current headlines, can help investors time the market. In addition, many technical investors use Chugai Pharmaceutical stock news signals to limit their universe of possible portfolio assets.
Chugai Pharmaceutical pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Chugai daily returns and investor perception about the current price of Chugai Pharmaceutical Co as well as its diversification or hedging effects on your existing portfolios.
  
over a month ago at news.google.com         
Chugai Pharmaceutical Enhances Governance for Sustainable Growth - TipRanks
Google News at Macroaxis
over a month ago at news.google.com         
Short Interest in Chugai Pharmaceutical Co., Ltd. Expands By .7 percent - MarketBeat
Google News at Macroaxis
over a month ago at news.google.com         
Japan stocks lower at close of trade Nikkei 225 down 1.05 percent - MSN
Google News at Macroaxis
over two months ago at news.google.com         
Chugai Pharmaceutical Co., Ltd.s Stock Has Fared Decently Is the Market Following Strong Financials ...
Google News at Macroaxis
over two months ago at news.google.com         
Chugai Pharmaceutical Co., Ltd. Just Beat Revenue By 12 percent Heres What Analysts Think Will Happe...
Google News at Macroaxis
over two months ago at news.google.com         
Chugai Earnings Full-Year Guidance Revised Upward Fair Value Raised 13 percent to JPY 5,900 - Mornin...
Google News at Macroaxis
over two months ago at news.google.com         
Chugai Pharmaceutical Third Quarter 2024 Earnings Beats Expectations - Simply Wall St
Google News at Macroaxis
over three months ago at news.google.com         
While institutions own 22 percent of Chugai Pharmaceutical Co., Ltd. , public companies are its larg...
Google News at Macroaxis
over three months ago at news.google.com         
Chugai Pharmaceutical Co., Ltd. Sees Significant Decrease in Short Interest - MarketBeat
Google News at Macroaxis
over three months ago at news.google.com         
Chugai Pharmaceutical Co., Ltd. Short Interest Update - MarketBeat
Google News at Macroaxis
over three months ago at news.google.com         
Is Chugai Pharmaceutical Co., Ltd.s Stocks Recent Performance Being Led By Its Attractive Financial ...
Google News at Macroaxis
over three months ago at news.google.com         
Chugai Pharmaceutical Co., Ltd. Short Interest Down 90.3 percent in July - MarketBeat
Google News at Macroaxis
over three months ago at news.google.com         
Chugai Pharmaceutical Second Quarter 2024 Earnings Beats Expectations - Simply Wall St
Google News at Macroaxis
over three months ago at news.google.com         
Chugai Pharmaceutical Is Due To Pay A Dividend Of 41.00 - Simply Wall St
Google News at Macroaxis
over three months ago at news.google.com         
Chugai Pharmaceutical Corrects Financial Statements - TipRanks
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Chugai Pharmaceutical that are available to investors today. That information is available publicly through Chugai media outlets and privately through word of mouth or via Chugai internal channels. However, regardless of the origin, that massive amount of Chugai data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Chugai Pharmaceutical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Chugai Pharmaceutical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Chugai Pharmaceutical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Chugai Pharmaceutical alpha.

Chugai Pharmaceutical Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Chugai Pink Sheet analysis

When running Chugai Pharmaceutical's price analysis, check to measure Chugai Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chugai Pharmaceutical is operating at the current time. Most of Chugai Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Chugai Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chugai Pharmaceutical's price. Additionally, you may evaluate how the addition of Chugai Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas